BioCentury
ARTICLE | Financial News

BioMedPartners closes third fund

March 1, 2018 6:11 PM UTC

BioMedPartners closed its BioMedInvest III fund at CHF100 million ($107 million). The firm plans to invest the fund in 12-15 private early to mid-stage pharmaceutical, medical device and diagnostics companies in Switzerland, Germany and neighboring EU countries (see BioCentury, Aug. 31, 2017).

The European Investment Fund was a cornerstone investor. Berner Kantonalbank also participated. ...